docetaxel anhydrous has been researched along with Canine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, D; Balkman, C; Beaulieu, BB; Flory, A; Kiselow, M; Lewis, LD; McEntee, M; Waite, A | 1 |
| Balkman, CE; Beaulieu, BB; Lewis, LD; McEntee, MC; Page, RL; Rassnick, KM; Zgola, MM | 1 |
2 trial(s) available for docetaxel anhydrous and Canine Diseases
| Article | Year |
|---|---|
Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cyclosporine; Dermatologic Agents; Docetaxel; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Male; Skin Neoplasms; Taxoids | 2014 |
Phase I and pharmacokinetic evaluation of the combination of orally administered docetaxel and cyclosporin A in tumor-bearing dogs.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cyclosporine; Docetaxel; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Male; Neoplasms; Taxoids | 2006 |